Morphine-induced venodilation in humans

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 5, 1996, Pages 554-560

  Grossmann, Matthias ^b   Abiose, Ademola ^b   Tangphao, Oranee ^b   Blaschke, Terrence F ^a   Hoffman, Brian B ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; FAMOTIDINE; FENTANYL; MORPHINE; NALOXONE; OPIATE RECEPTOR; PHENYLEPHRINE;

ADULT; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0029804420     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90151-4     Document Type: Article

References (29)

1. Gazes P. Treatment of acute pulmonary edema. Heart Dis Stroke 1994;3:205-9.
2. Zelis R, Mansour E, Capone R, Mason D, Kleckner R. The cardiovascular effects of morphine. J Clin Invest 1974;54:1247-58.
3. Lowenstein E, Whiting R, Bittar D, Sanders C, Powell W Jr. Local and neurally mediated effects of morphine on skeletal muscle vascular resistance. J Pharmacol Exp Ther 1972;180:359-67.
4. Evans A, Nasmyth P, Stewart H. The fall of blood pressure caused by intravenous morphine in the rat and the cat. Br J Pharmacol 1952;7:542-52.
5. El Sharkawy T, Al Shireida M, Pilcher C. Vascular effects of some opioid receptor agonists. Can J Physiol Pharmacol 1991;69:846-51.
6. Henney R, Vasko J, Brawley R, Oldham H, Morrow A. The effects of morphine on the resistance and capacitance vessels of the peripheral circulation. Am Heart J 1966;72:242-50.
7. Popio K, Jackson D, Ross A, Schreiner B, Yu P. Hemodynamic and respiratory effects of morphine and butorphanol. Clin Phamacol Ther 1978;23:281-7.
8. Rosow C, Moss J, Philbin D, Savarese J. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982;56:93-6.
9. Withington D, Patrick J, Reynolds F. Histamine release by morphine and diamorphine in man. Anaesthesia 1993;48:26-9.
10. Moss J, Rosow C. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983;59: 330-9.
11. Fahmy N, Sunder N, Soter N. Role of histamine in the hemodynamic response and plasma catecholamine response to morphine. Clin Pharmacol Ther 1983;33: 615-20.
12. Doenicke A, Moss J, Lorenz W, Hoernecke R. Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 1995;58: 81-9.
13. Barke K, Hough LB. Opiates, mast cells and histamine release. Clin Sci 1993;53:1391-9.
14. Levy J, Brister N, Shearin A, Ziegler J, Hug C, Adelson DM, et al. Wheal and flare responses to opioids in humans. Anesthesiology 1989;70:756-60.
15. Hermens J, Ebertz J, Hanifin J, Hirshman C. Comparison of histamine release in skin mast cells induced by morphine, fentanyl, and oxymorphone. Anesthesiology 1985;62:124-9.
16. Stellato C, Cirillo R, dePaulis A, Casolaro V, Patella V, Mastronardi P, et al. Human basophil/mast cell releasability; IX: heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992;77: 932-40.
17. Pan H, Hoffmann B, Pershe RA, Blaschke TF. Decline in beta adrenergic receptor-mediated relaxation with aging in man. J Pharmacol Exp Ther 1986;239: 802-7.
18. Kenakin TP. Pharmacologie analysis of drug-receptor interactions. New York: Raven Press, 1987:205-44.
19. Hustvet O, Setekleix J, Oye I. Naloxone counteracts fast development of tolerance to morphine in guinea pig ileum. Pharmacol Toxicol 1992;71:224-8.
20. Dachman W, Bedarida G, Blaschke TF, Hoffman BB. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J Allergy Clin Immunol 1994;93:606-14.
21. De Lean A, Munson P, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
22. Ballantyne J, Loach A, Carr D. Itching after epidural and spinal opiates. Pain 1988;33:149-60.
23. Bergasa N, Talbot T, Alling D, Schmitt JM, Walker EC, Baker BL, et al. A controlled clinical trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-9.
24. Jones E, Bergasa N. The pruritus of cholestasis and the opioid system [clinical conference]. JAMA 1992; 268:3359-67.
25. Chikai T, Oishi R, Saeki K. Increase in the extracellular histamine concentration in the rat striatum by mu-opioid receptor activation. J Neurochem 1994;62: 724-9.
26. Jaffe J, Martin W. Opioid analgesics and antagonists. Goodman & Gilman's The pharmacological basis of therapeutics. 8th edition. New York: Pergamon Press, 1984:485-521.
27. Patella V, de Crescendo G, Ciccarelli A, Marino I, Adt M, Marone G. Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 1995;106:386-93.
28. Mousli M, Bronner C, Bueb J, Landry Y. Evidence for the interaction of mast cell-degranulating peptide with pertussis toxin-sensitive G proteins in mast cells. Eur J Pharmacol 1991;207:249-55.
29. Higashijima T, Burnier J, Ross E. Regulation of Gi and Go by mastoparan, related amphophilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem 1990;265:14176-86.